F.D.A. Approves New Eli Lilly Weight-Loss Pill, Foundayo - The New York Times

The New York Times·Apr 1

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

The US Food and Drug Administration has approved a new weight-loss pill called Foundayo, developed by Eli Lilly. The pill, which is a GLP-1 medication, has been approved for weight loss and can be taken at any time of day without food or water restrictions. Foundayo is reportedly an oral, once-daily medication, giving patients another option for treating obesity.

Full coverage

FDA approves Eli Lilly’s weight-loss pill; Judge revokes citizenship over stolen medical secrets for China; new COVID-19 ‘Cicada’ variant spreads to 25 states – Morning Medical Update

Medical Economics·1d ago

FDA approves GLP-1 weight loss pill Foundayo from Eli Lilly

NBC News·Apr 1

FDA approves Eli Lilly's GLP-1 pill, opening the next phase of the weight loss drug market

CNBC·Apr 1

FDA Approves Eli Lilly's Obesity Pill, Foundayo

Time Magazine·Apr 2

FDA approves Lilly's Foundayo™ (orforglipron), the only GLP-1 pill for weight loss that can be taken any time of day without food or water restrictions

PR Newswire·Apr 1

The FDA approves a new obesity pill, giving patients another option

NPR·Apr 1

FDA Approves New Oral Weight Loss Pill Foundayo — Here’s What To Know

Forbes·Apr 3

Explainer: What to Know About Foundayo, Eli Lilly’s New Once-Daily Weight-Loss Pill

U.S. News & World Report·Apr 2

View original report at The New York Times ↗

Fetching the latest headlines…